Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current controversies in prenatal diagnosis 1: should noninvasive DNA testing be the standard screening test for Down syndrome in all pregnant women?

3 Sept 2013

Abstract excerpt

What's already known about this topic? Noninvasive DNA testing (NIDT) is recommended in many developed countries as an option for pregnant women who have already been determined to be at high risk for fetal aneuploidy. Over 2 years of clinical experience has been accumulated with offering NIDT as an advanced screen for fetal autosomal aneuploidy. At the present time, most testing is being performed by commercial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fetal and Pediatric Neurological Disorders
Share to Parvovirus B19 Infection Studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24002925
DOI: 10.1002/pd.4229

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current controversies in prenatal diagnosis 1: should noninvasive DNA testing be the standard screening test for Down syndrome in all pregnant women?PMID 24002925Read ↗

Current controversies in prenatal diagnosis 2: Cell‐free DNA prenatal screening should be used to identify all chromosome abnormalitiesSemantic proximity Read ↗

ACOG Practice Bulletin No. 88: Invasive Prenatal Testing for AneuploidySemantic proximity Read ↗

Has Noninvasive Prenatal Testing Impacted Termination of Pregnancy and Live Birth Rates of Infants With Down Syndrome?Semantic proximity Read ↗

Cell-Free DNA Testing for Fetal Chromosomal Anomalies in clinical practice: Austrian-German-Swiss Recommendations for non-invasive prenatal tests (NIPT)Semantic proximity Read ↗

Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011Semantic proximity Read ↗

Non-Invasive Prenatal Testing (NIPT): Reliability, Challenges, and Future DirectionsSemantic proximity Read ↗

Noninvasive prenatal testing for aneuploidy using cell-free DNA – New implications for maternal healthSemantic proximity Read ↗

ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practiceSemantic proximity Read ↗

Non-Invasive Prenatal Screening from a Genetic Counseling Prospective: Pre and Post-Genetic Counseling Regarding Rare Chromosomal Abnormalities and Incidental FindingSemantic proximity Read ↗

Non-invasive prenatal testing in Germany: a unique ethical and policy landscapeSemantic proximity Read ↗

Initial experience with non-invasive prenatal testing of cell-free DNA for major chromosomal anomalies in a clinical settingSemantic proximity Read ↗

Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screeningSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.